Next Article in Journal
Declining Conventional Cancer Treatment and Using Complementary and Alternative Medicine: A Problem or a Challenge?
Previous Article in Journal
Progression-Free Survival in Advanced Ovarian Cancer: A Canadian Review and Expert Panel Perspective
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 18
Issue 6
10.3747/co.v18i6.998
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Erratum

Corrigendum: Progression-Free Survival in Advanced Ovarian Cancer: A Canadian Review and Expert Panel Perspective

by
A. M. Oza
1,
V. Castonguay
1,
D. Tsoref
1,
I. Diaz-Padilla
1,
K. Karakasis
1,
H. Mackay
1,
S. Welch
2,
J. Weberpals
3,
P. Hoskins
4,
M. Plante
5,
D. Provencher
6,
K. Tonkin
7,
A. Covens
8,
P. Ghatage
9,
J. Gregoire
10,
H. Hirte
11,
D. Miller
4,
B. Rosen
1,
J. Bentley
12,
J. Maroun
3,
M. Buysse
10,
C. Coens
13,
M. F. Brady
14 and
G. C. E. Stuart
15add Show full author list remove Hide full author list
1
Princess Margaret Hospital, Toronto, ON, Canada
2
London Health Sciences Centre, London, ON, Canada
3
The Ottawa Hospital, Ottawa, ON, Canada
4
BC Cancer Agency, Vancouver, BC, Canada
5
Department of Obstetrics and Gynecology, Laval University, Laval, QC, Canada
6
Division of Gynecologic Oncology, Université de Montréal, Institut du Cancer de Montréal, Centre Recherche CHUM, Montreal, QC, Canada
7
Cross Cancer Institute, Edmonton, AB, Canada
8
Toronto–Sunnybrook Regional Cancer Centre, Toronto, ON, Canada
9
Tom Baker Cancer Centre, Calgary, AB, Canada
10
CHUQ–Hotel-Dieu de Quebec, Quebec City, QC, Canada
11
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada
12
Division of Gynecologic Oncology, Dalhousie University, Halifax, NS, Canada
13
European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium
14
Roswell Park Cancer Institute, Buffalo, NY, USA
15
University of British Columbia, Vancouver, BC, Canada
 
add Show full affiliation list
 
remove Hide full affiliation list
Curr. Oncol. 2011, 18(6), 303; https://doi.org/10.3747/co.v18i6.998
Submission received: 1 December 2011 / Revised: 1 December 2011 / Accepted: 1 December 2011 / Published: 1 December 2011
Versions Notes

Conflict Of Interest Disclosures

AMO has participated on advisory boards for AstraZeneca, Celgene Corporation, and Sanofi–Aventis. JW has participated on the drug advisory board for AstraZeneca. AC has served on advisory boards and speakers’ bureaus for Amgen, Roche, GlaxoSmithKline, and Merck. JB has served on advisory boards for Schering–Plough and Roche. MB holds stock in IDDI.

Original Citation

Curr Oncol 2011;18(Suppl 2):S20–7. Published online September 26, 2011; corrected after print November 14, 2011.

Author’s Description of Error

It has come to our attention that, over the course of putting together this article, we inadvertently forgot to include one of our colleagues, Dr. James Bentley, who had participated in initial discussions. This omission was a complete oversight on our part.
The correct author list, affiliations, and conflict of interest disclosures appear above. The error has been corrected in the HTML and PDF versions of the article.

Share and Cite

MDPI and ACS Style

Oza, A.M.; Castonguay, V.; Tsoref, D.; Diaz-Padilla, I.; Karakasis, K.; Mackay, H.; Welch, S.; Weberpals, J.; Hoskins, P.; Plante, M.; et al. Corrigendum: Progression-Free Survival in Advanced Ovarian Cancer: A Canadian Review and Expert Panel Perspective. Curr. Oncol. 2011, 18, 303. https://doi.org/10.3747/co.v18i6.998

AMA Style

Oza AM, Castonguay V, Tsoref D, Diaz-Padilla I, Karakasis K, Mackay H, Welch S, Weberpals J, Hoskins P, Plante M, et al. Corrigendum: Progression-Free Survival in Advanced Ovarian Cancer: A Canadian Review and Expert Panel Perspective. Current Oncology. 2011; 18(6):303. https://doi.org/10.3747/co.v18i6.998

Chicago/Turabian Style

Oza, A. M., V. Castonguay, D. Tsoref, I. Diaz-Padilla, K. Karakasis, H. Mackay, S. Welch, J. Weberpals, P. Hoskins, M. Plante, and et al. 2011. "Corrigendum: Progression-Free Survival in Advanced Ovarian Cancer: A Canadian Review and Expert Panel Perspective" Current Oncology 18, no. 6: 303. https://doi.org/10.3747/co.v18i6.998

APA Style

Oza, A. M., Castonguay, V., Tsoref, D., Diaz-Padilla, I., Karakasis, K., Mackay, H., Welch, S., Weberpals, J., Hoskins, P., Plante, M., Provencher, D., Tonkin, K., Covens, A., Ghatage, P., Gregoire, J., Hirte, H., Miller, D., Rosen, B., Bentley, J., ... Stuart, G. C. E. (2011). Corrigendum: Progression-Free Survival in Advanced Ovarian Cancer: A Canadian Review and Expert Panel Perspective. Current Oncology, 18(6), 303. https://doi.org/10.3747/co.v18i6.998

Article Metrics

Back to TopTop